Progenitor cell-based treatment of the pediatric myelin disorders
about
How to make an oligodendrocyteOutcomes of autologous bone marrow mononuclear cells for cerebral palsy: an open label uncontrolled clinical trial.Neural stem cell therapy for cancer.Generation of oligodendroglial cells by direct lineage conversion.Stem cell therapy. Use of differentiated pluripotent stem cells as replacement therapy for treating disease.Glia Disease and Repair-RemyelinationModeling cognition and disease using human glial chimeric miceCD140a identifies a population of highly myelinogenic, migration-competent and efficiently engrafting human oligodendrocyte progenitor cells.Hydrogel formulation determines cell fate of fetal and adult neural progenitor cellsGlial progenitor cell-based treatment and modeling of neurological diseaseGlial-Restricted Precursors Protect Neonatal Brain Slices from Hypoxic-Ischemic Cell Death Without Direct Tissue ContactElectric Signals Regulate the Directional Migration of Oligodendrocyte Progenitor Cells (OPCs) via β1 Integrin.Stem and Progenitor Cell-Based Therapy of the Central Nervous System: Hopes, Hype, and Wishful Thinking.Concise Review: Stem Cell-Based Treatment of Pelizaeus-Merzbacher Disease.Isolation and long-term expansion of functional, myelinating oligodendrocyte progenitor cells from neonatal rat brain.Human oligodendrocytes in remyelination research.Efficient Generation of Viral and Integration-Free Human Induced Pluripotent Stem Cell-Derived Oligodendrocytes.A clinical study of autologous bone marrow mononuclear cells for cerebral palsy patients: a new frontier.Neurogenetics: Five new things.
P2860
Q26775534-4D0A8041-239F-487D-9C43-716DD9EA68B9Q33556222-9CDB8658-26C8-424F-83BA-199A3DC2A4D7Q33704489-F29983E4-4195-447D-A7BA-28503F025F37Q34339119-1CCA861C-C3A7-4F97-AC6E-8005873C3700Q35087066-AD803376-081A-41CC-AB88-7E8B10ECFE8EQ35795587-7B58141B-0082-4B2F-80D6-CFDD7F1ECDF3Q35924207-9B0F5521-1A0F-48AB-AD33-6D0E585D649CQ36002391-933A6937-D060-4719-B945-F07BDA144920Q36393930-097B592B-8F8A-4659-981E-280471BE7DB8Q36544289-10625E5B-FF87-42CF-8BD0-66D6D5773300Q37061164-B3F2AD5A-984A-48C8-8E97-F880ED3246FEQ37465768-DE9EFFC1-D908-4B8D-92B0-2515073BE727Q37643268-33D7088F-1E20-4C57-8B42-392504DC4492Q37649702-BA3F7317-02B6-4D52-8407-BC0AE992CCE0Q38264741-455FC79C-5C83-49F7-853C-CACCCE646756Q38271155-72A3FD34-E36E-4D66-9F0E-5C5F4A149E56Q40618763-EC2BFEFD-35F2-41F9-8D36-767EDEEC7FD2Q41997884-F2B6459A-EB62-4F44-A037-3E1C0E37E4CCQ49775943-B0835DD2-1841-4BC8-A2E2-F7B4998AD60F
P2860
Progenitor cell-based treatment of the pediatric myelin disorders
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Progenitor cell-based treatment of the pediatric myelin disorders
@ast
Progenitor cell-based treatment of the pediatric myelin disorders
@en
type
label
Progenitor cell-based treatment of the pediatric myelin disorders
@ast
Progenitor cell-based treatment of the pediatric myelin disorders
@en
prefLabel
Progenitor cell-based treatment of the pediatric myelin disorders
@ast
Progenitor cell-based treatment of the pediatric myelin disorders
@en
P2860
P1433
P1476
Progenitor cell-based treatment of the pediatric myelin disorders
@en
P2093
Steven A Goldman
P2860
P304
P356
10.1001/ARCHNEUROL.2011.46
P577
2011-03-14T00:00:00Z